Conference Coverage

Bloating. Flatulence. Think SIBO


 

EXPERT ANALYSIS FROM RWCS 2018

Indeed, 40% of patients will experience recurrent SIBO symptoms within 9 months after a round of rifaximin. Recurrences are more common in patients on chronic proton pump–inhibitor therapy, the elderly, and those who have undergone appendectomy. Such patients may need another course of rifaximin once or twice per year.

“If they need rifaximin every 6 months, fine. Patients will be so grateful to you for that course of rifaximin,” Dr. Mahadevan said.

Patients with methane-predominant bacterial overgrowth, as opposed to hydrogen-predominant overgrowth, often benefit from concomitant neomycin at 500 mg twice per day along with their 10-14 days of rifaximin.

“A lot of our cirrhotic patients are on both,” she noted.

Pages

Recommended Reading

Low risk of bariatric surgery complications in IBD
MDedge Endocrinology
Autoimmune endocrinopathies spike after celiac disease diagnosis
MDedge Endocrinology
Eliminating patient-controlled analgesia accelerates discharge after bariatric surgery
MDedge Endocrinology
Large database analysis suggests safety of bariatric surgery in seniors
MDedge Endocrinology
Cancer patients with TKI-induced hypothyroidism had better survival rates
MDedge Endocrinology
The Liver Meeting 2017 NAFLD debrief – key abstracts
MDedge Endocrinology
Does incretin therapy increase pancreatic cancer risk?
MDedge Endocrinology
Higher BMI linked to problems for IBD patients
MDedge Endocrinology
Expert: Eat walnuts!
MDedge Endocrinology
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Endocrinology